A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.
<h4>Aims</h4>Obstructive sleep apnea (OSA) is a widespread disease with high global socio-economic impact. However, detailed pathomechanisms are still unclear, partly because current animal models of OSA do not simulate spontaneous airway obstruction. We tested whether polytetrafluoroeth...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0243844 |
id |
doaj-e0cfb62000834f6189841a97ca8aa2d6 |
---|---|
record_format |
Article |
spelling |
doaj-e0cfb62000834f6189841a97ca8aa2d62021-03-04T12:58:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011512e024384410.1371/journal.pone.0243844A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.Simon LebekPhilipp HegnerChristian SchachKathrin ReuthnerMaria TafelmeierLars Siegfried MaierMichael ArztStefan Wagner<h4>Aims</h4>Obstructive sleep apnea (OSA) is a widespread disease with high global socio-economic impact. However, detailed pathomechanisms are still unclear, partly because current animal models of OSA do not simulate spontaneous airway obstruction. We tested whether polytetrafluoroethylene (PTFE) injection into the tongue induces spontaneous obstructive apneas.<h4>Methods and results</h4>PTFE (100 μl) was injected into the tongue of 31 male C57BL/6 mice and 28 mice were used as control. Spontaneous apneas and inspiratory flow limitations were recorded by whole-body plethysmography and mRNA expression of the hypoxia marker KDM6A was quantified by qPCR. Left ventricular function was assessed by echocardiography and ventricular CaMKII expression was measured by Western blotting. After PTFE injection, mice showed features of OSA such as significantly increased tongue diameters that were associated with significantly and sustained increased frequencies of inspiratory flow limitations and apneas. Decreased KDM6A mRNA levels indicated chronic hypoxemia. 8 weeks after surgery, PTFE-treated mice showed a significantly reduced left ventricular ejection fraction. Moreover, the severity of diastolic dysfunction (measured as E/e') correlated significantly with the frequency of apneas. Accordingly, CaMKII expression was significantly increased in PTFE mice and correlated significantly with the frequency of apneas.<h4>Conclusions</h4>We describe here the first mouse model of spontaneous inspiratory flow limitations, obstructive apneas, and hypoxia by tongue enlargement due to PTFE injection. These mice develop systolic and diastolic dysfunction and increased CaMKII expression. This mouse model offers great opportunities to investigate the effects of obstructive apneas.https://doi.org/10.1371/journal.pone.0243844 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Simon Lebek Philipp Hegner Christian Schach Kathrin Reuthner Maria Tafelmeier Lars Siegfried Maier Michael Arzt Stefan Wagner |
spellingShingle |
Simon Lebek Philipp Hegner Christian Schach Kathrin Reuthner Maria Tafelmeier Lars Siegfried Maier Michael Arzt Stefan Wagner A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction. PLoS ONE |
author_facet |
Simon Lebek Philipp Hegner Christian Schach Kathrin Reuthner Maria Tafelmeier Lars Siegfried Maier Michael Arzt Stefan Wagner |
author_sort |
Simon Lebek |
title |
A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction. |
title_short |
A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction. |
title_full |
A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction. |
title_fullStr |
A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction. |
title_full_unstemmed |
A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction. |
title_sort |
novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2020-01-01 |
description |
<h4>Aims</h4>Obstructive sleep apnea (OSA) is a widespread disease with high global socio-economic impact. However, detailed pathomechanisms are still unclear, partly because current animal models of OSA do not simulate spontaneous airway obstruction. We tested whether polytetrafluoroethylene (PTFE) injection into the tongue induces spontaneous obstructive apneas.<h4>Methods and results</h4>PTFE (100 μl) was injected into the tongue of 31 male C57BL/6 mice and 28 mice were used as control. Spontaneous apneas and inspiratory flow limitations were recorded by whole-body plethysmography and mRNA expression of the hypoxia marker KDM6A was quantified by qPCR. Left ventricular function was assessed by echocardiography and ventricular CaMKII expression was measured by Western blotting. After PTFE injection, mice showed features of OSA such as significantly increased tongue diameters that were associated with significantly and sustained increased frequencies of inspiratory flow limitations and apneas. Decreased KDM6A mRNA levels indicated chronic hypoxemia. 8 weeks after surgery, PTFE-treated mice showed a significantly reduced left ventricular ejection fraction. Moreover, the severity of diastolic dysfunction (measured as E/e') correlated significantly with the frequency of apneas. Accordingly, CaMKII expression was significantly increased in PTFE mice and correlated significantly with the frequency of apneas.<h4>Conclusions</h4>We describe here the first mouse model of spontaneous inspiratory flow limitations, obstructive apneas, and hypoxia by tongue enlargement due to PTFE injection. These mice develop systolic and diastolic dysfunction and increased CaMKII expression. This mouse model offers great opportunities to investigate the effects of obstructive apneas. |
url |
https://doi.org/10.1371/journal.pone.0243844 |
work_keys_str_mv |
AT simonlebek anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT philipphegner anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT christianschach anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT kathrinreuthner anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT mariatafelmeier anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT larssiegfriedmaier anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT michaelarzt anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT stefanwagner anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT simonlebek novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT philipphegner novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT christianschach novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT kathrinreuthner novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT mariatafelmeier novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT larssiegfriedmaier novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT michaelarzt novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction AT stefanwagner novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction |
_version_ |
1714801017714900992 |